Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA1 founder mutations compared to ovarian cancer in Belarus.

Familial cancer - 1 Sept 2014

Savanevich Alena, Oszurek Oleg, Lubiński Jan, Cybulski Cezary, Dębniak Tadeusz, Narod Steven A, Gronwald Jacek

Abstract excerpt

In Belarus and other Slavic countries, founder mutations in the BRCA1 gene are responsible for a significant proportion of breast cancer cases, but the data on contribution of these mutations to ovarian cancers are limited. To estimate the proportion of ovarian cancers in Belarus, which are dependent on BRCA1 Slavic founder mutations, we sought the presence of three most frequent mutations (BRCA1: 5382insC, C61G...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Founder Effect

Share to Genes, BRCA1

Share to Ovarian Neoplasms

Share to Polymerase Chain Reaction

Share to Polymorphism, Restriction Fragment Length

Share to Republic of Belarus

Source

Open in PubMed Open full text

Identifiers

PMID: 24770866
DOI: 10.1007/s10689-014-9721-8
PMCID: PMC4164833

Genes

BRCA1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA1 founder mutations compared to ovarian cancer in Belarus.PMID 24770866Read ↗

BRCA1 and BRCA2 mutations in ovarian cancer patients from Belarus: updateSemantic proximity Read ↗

The contribution of founder mutations in BRCA1 to breast cancer in Belarus.Semantic proximity Read ↗

High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus.Semantic proximity Read ↗

Founder vs. non-founder BRCA1/2 pathogenic alleles: the analysis of Belarusian breast and ovarian cancer patients and review of other studies on ethnically homogenous populations.Semantic proximity Read ↗

A high proportion of founder BRCA1 mutations in Polish breast cancer families.Semantic proximity Read ↗

Frequency of BRCA1 and BRCA2 causative founder variants in ovarian cancer patients in South-East PolandSemantic proximity Read ↗

Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients.Semantic proximity Read ↗

Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.Semantic proximity Read ↗

High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patientsSemantic proximity Read ↗

Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin.Semantic proximity Read ↗

The contribution of founder mutations in BRCA1 to breast and ovarian cancer in Lithuania.Semantic proximity Read ↗

BRCA1 mutations in South African breast and/or ovarian cancer families: evidence of a novel founder mutation in Afrikaner families.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.